| Literature DB >> 26310697 |
Cassandra J Adams1, Jennifer S Yu2, Jian-Hua Mao3, Kuang-Yu Jen4, Sylvain V Costes3, Mark Wade5, Jocelyn Shoemake2, Olulanu H Aina6, Reyno Del Rosario1, Phuong Thuy Menchavez1, Robert D Cardiff6, Geoffrey M Wahl7, Allan Balmain1.
Abstract
The tumor suppressor TP53 can initiate a plethora of anti-proliferative effects to maintain genomic integrity under conditions of genotoxic stress. The N-terminal proline-rich domain (PRD) of TP53 is important in the regulation of TP53 activity and stability. A common polymorphism at codon 72 in this region has been associated with altered cancer risk in humans. The Trp53ΔP mouse, which carries a germline homozygous deletion of a region of the PRD, does not develop spontaneous tumors in a mixed 129/Sv and C57BL/6 genetic background, but is highly susceptible to a broad range of tumor types following total body exposure to 4 Gy gamma (γ) radiation. This contrasts with the tumor spectrum in Trp53 null (-/-) mice, which mainly develop thymic lymphomas and osteosarcomas. Analysis of genomic instability in tissues and cells from Trp53ΔP mice demonstrated elevated basal levels of aneuploidy, but this is not sufficient to drive spontaneous tumorigenesis, which requires an additional DNA damage stimulus. Levels of genomic instability did not increase significantly in Trp53ΔP mice following irradiation exposure, suggesting that other radiation effects including tissue inflammation, altered metabolism or autophagy, may play an important role. The Trp53ΔP mouse is a novel model to dissect the mechanisms of tumor development induced by radiation exposure.Entities:
Keywords: Trp53; cancer radiation; genomic instability
Mesh:
Substances:
Year: 2015 PMID: 26310697 PMCID: PMC4891300 DOI: 10.1002/mc.22377
Source DB: PubMed Journal: Mol Carcinog ISSN: 0899-1987 Impact factor: 4.784